Shar Matin

COO

ViewRay

$400

Requested Donation

Shar's Summary

Over 20 years of medical device experience in Fortune 500 and mid/small cap companies. Led commercial and technical teams in the United States, Europe and Asia. Currently as COO of Viewray Inc, a disruptive radiation oncology equipment manufacturer and previously as Chief Operating Officer of Spectranetics prior to its $2.2 billion acquisition by Royal Philips. During tenure, Spectranetics grew from $63 million to nearly $300 million in revenues and the enterprise value increased from $250 million to over $2 billion. Prior to Spectranetics, held various commercial and technical leadership roles at Boston Scientific and Guidant.

About Shar

  • Span of Control

    The number of people reporting to them

    Oct-49

  • Industry

    Health care

  • Size of Company

    In terms of revenue

    $50 - $99 Million

  • Employees of Company

    The number of people working for this company

    11-100

  • Business Function

    Operations

Interested in meeting with Shar?

Click here to learn more!

My "Bold Ask" to Vendors

...compelling reasons I would take a meeting.

Meetings I'm Not Interested In

Supported Causes & Charities